Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 16;14(1):30469.
doi: 10.1038/s41598-024-77360-3.

Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy from Japanese cohorts

Affiliations

Sarcomere gene variants did not improve cardiac function in pediatric patients with dilated cardiomyopathy from Japanese cohorts

Keiichi Hirono et al. Sci Rep. .

Abstract

Dilated cardiomyopathy (DCM) is a progressive myocardial disorder characterized by impaired cardiac contraction and ventricular dilation. However, some patients with DCM improve when experiencing left ventricular reverse remodeling (LVRR). Currently, the detailed association between genotypes and clinical outcomes, including LVRR, particularly among children, remains uncertain. Pediatric patients with DCM from multiple Japanese institutions recorded between 2014 and 2023 were enrolled. We identified their DCM-related genes and explored the association between gene variants and clinical outcomes, including LVRR. We included 123 pediatric patients (62 males; median age: 8 [1-51] months) and found 50 pathogenic variants in 45 (35.0%) of them. The most identified gene was MYH7 (14.0%), followed by RYR2 (12.0%) and TPM1 (8.0%). LVRR was achieved in 47.5% of these patients. The left ventricular ejection fraction remained unchanged (31.4% to 39.8%, P = 0.1913) in patients with sarcomere gene variants and in those with non-sarcomere gene variants (33.4% to 47.8%, P = 0.0522) but significantly increased in those without gene variants (33.6% to 54.1%, P < 0.0001). LVRR was not uniform across functional gene groups. Hence, an individualized gene-guided prediction approach may be adopted for children with DCM.

Keywords: Dilated cardiomyopathy; Genetics; Heart failure; Left ventricular reverse remodeling; Sarcomere gene.

PubMed Disclaimer

Conflict of interest statement

Declarations. Competing interests: The authors declare no competing interests.

Figures

Fig. 1
Fig. 1
Age distribution of the patients.
Fig. 2
Fig. 2
Comparison of serial echocardiographic data for the entire cohort and among patients according to variants. Left ventricular ejection fraction (LVEF) from baseline to follow-up for the entire cohort (A) and among patients according to variants: sarcomere gene variant (n = 7), non-sarcomere gene variant (n = 12), and negative variant (n = 22). (B) Left ventricular diastolic diameter (LVDD) Z-score from baseline to follow-up for the entire cohort (C) and among patients according to variants: sarcomere gene variant (n = 7), non-sarcomere gene variant (n = 12), and negative variant (n = 22) (D).
Fig. 3
Fig. 3
Genetic distribution of DCM. The genetic architecture of DCM spans 6 gene functions, as shown in the outermost colored text circle.
Fig. 4
Fig. 4
Left ventricular reverse remodeling rate. Left ventricular reverse remodeling rate at the last follow-up in variant-positive versus variant-negative patients with dilated cardiomyopathy (DCM) (A) and the functional gene group in variant-positive patients with DCM (B).
Fig. 5
Fig. 5
Kaplan–Meier analysis and time from diagnosis to life-threatening cardiac outcome. Event-free survival (A) and freedom from major adverse cardiac events (MACE) (B) in patients with dilated myocardiopathy (DCM). Event-free survival in patients with DCM (C) according to age (D) and plasma BNP levels. Kaplan–Meier curves were compared using the log-rank test.

References

    1. Fatkin, D., Huttner, I. G., Kovacic, J. C., Seidman, J. G. & Seidman, C. E. Precision medicine in the management of dilated cardiomyopathy: JACC state-of-the-art review. J Am Coll Cardiol74, 2921–2938. 10.1016/j.jacc.2019.10.011 (2019). - PubMed
    1. McKenna, W. J. & Judge, D. P. Epidemiology of the inherited cardiomyopathies. Nat Rev Cardiol18, 22–36. 10.1038/s41569-020-0428-2 (2021). - PubMed
    1. Mori, H. et al. CORRIGENDUM: Outcomes of dilated cardiomyopathy in japanese children - A retrospective cohort study. Circ J86, 916–917. 10.1253/circj.CJ-66-0204 (2022). - PubMed
    1. Lipshultz, S. E. et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med348, 1647–1655. 10.1056/NEJMoa021715 (2003). - PubMed
    1. Kirk, R. et al. The International Society for Heart and Lung Transplantation Guidelines for the management of pediatric heart failure: Executive summary. [Corrected]. J Heart Lung Transplant33, 888–909, 10.1016/j.healun.2014.06.002 (2014). - PubMed

LinkOut - more resources